DR. LAL PATH LABS
LALPATHLABVerifiedDR. LAL PATH LABS is a publicly traded security listed on the NSE/BSE exchange.
Stock Snapshot & Key Numbers — DR. LAL PATH LABS
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
DR. LAL PATH LABS (LALPATHLAB) is a Indian equity security listed on the NSE/BSE with ISIN BSE:539524. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹1859.90, recording a -25.20 (-1.34%) decline from its previous close of ₹1885.10. Over the trailing 52-week trading cycle, LALPATHLAB has traded between a 52-week low of ₹1307.60 and a 52-week high of ₹2005.10, establishing its annual trading channel. In historical performance, DR. LAL PATH LABS has gained 17.84% over the past 1 year. Period returns across standard measurement intervals include: 1-week: -3.81%, 1-month: -1.89%, 6-month: +31.83%, 1-year: +17.84%, 3-year: +45.63%, 5-year: +3.12%. Daily reported trading volume reached 2,45,047 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 59.7x and a price-to-book (P/B) ratio of 12.9x, with a trailing dividend yield of 1.03%. Its market capitalization stands at ₹32,331.86 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)
How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| NIFTY 50 | +0.40 | +0.19 | Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +0.40% co-movement (correlation: 0.19). Descriptive historical relationship, not predictive. |
| USD / INR | -0.33 | -0.09 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.33% co-movement (correlation: -0.09). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | -0.05 | -0.10 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.05% co-movement (correlation: -0.10). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | +0.00 | +0.00 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a +0.00% co-movement (correlation: 0.00). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹1,933.60 | ₹1,859.90 | -3.81% |
| 15 Days | ₹2,005.10 | ₹1,859.90 | -7.24% |
| 1 Month | ₹1,895.70 | ₹1,859.90 | -1.89% |
| 3 Months | ₹1,732.70 | ₹1,859.90 | +7.34% |
| 6 Months | ₹1,410.80 | ₹1,859.90 | +31.83% |
| 1 Year | ₹1,578.35 | ₹1,859.90 | +17.84% |
| 3 Years | ₹1,277.15 | ₹1,859.90 | +45.63% |
| 5 Years | ₹1,803.55 | ₹1,859.90 | +3.12% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹1,509.80 | ₹1,859.90 | +23.2% | |
| CY 2025 | ₹1,526.53 | ₹1,482.60 | -2.9% | |
| CY 2024 | ₹1,287.68 | ₹1,500.20 | +16.5% | |
| CY 2023 | ₹1,100.07 | ₹1,288.85 | +17.2% | |
| CY 2022 | ₹1,930.65 | ₹1,130.22 | -41.5% | |
| CY 2021 | ₹1,803.55 | ₹1,911.13 | +6.0% |
Historical Investment Simulator
Factual simulation of past returns in DR. LAL PATH LABS (LALPATHLAB) using real recorded closing prices.
Corporate Actions & Distributions
Historical record of dividend payouts and share split adjustments for LALPATHLAB.
Dividend Distributions (4)
| Ex-Date | Dividend Amount |
|---|---|
| 30 Jul 2026 | ₹5.00 per share |
| 25 Jun 2026 | ₹4.00 per share |
| 5 Feb 2026 | ₹3.50 per share |
| 7 Nov 2025 | ₹3.50 per share |
Stock Splits & Multipliers (1)
| Effective Date | Split Ratio |
|---|---|
| 19 Dec 2025 | 2:1 |
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
Dr. Lal Path Labs Q1 profit jumps 28% YoY, dividend of ₹5 apiece declared; shares gain over 2% - Upstox
Dr. Lal Path Labs Q1 profit jumps 28% YoY, dividend of ₹5 apiece declared; shares gain over 2% Upstox
Dr. Lal Path Labs Share Price - Live NSE: LALPATHLAB Stock Price & Chart - Upstox
Dr. Lal Path Labs Share Price - Live NSE: LALPATHLAB Stock Price & Chart Upstox
Dr. Lal Path Labs (LALPATHLAB.NS) Eases 0.93% to ₹1934.2 as Diagnostics Major Holds Above Key Support - BPI Bull Confirmed - siam.in
Dr. Lal Path Labs (LALPATHLAB.NS) Eases 0.93% to ₹1934.2 as Diagnostics Major Holds Above Key Support - BPI Bull Confirmed siam.in
Dr. Lal Path Labs (LALPATHLAB.NS) Slips 0.56% to ₹1,895.7 as Support at ₹1,800.91 Comes Into Focus - Up Down Volume - siam.in
Dr. Lal Path Labs (LALPATHLAB.NS) Slips 0.56% to ₹1,895.7 as Support at ₹1,800.91 Comes Into Focus - Up Down Volume siam.in
Dr. Lal Path Labs (LALPATHLAB.NS) Holds Near ₹1,916; Range-Bound Move Signals Cautious Optimism - MA Crossover - https://www.siam.in/
Dr. Lal Path Labs (LALPATHLAB.NS) Holds Near ₹1,916; Range-Bound Move Signals Cautious Optimism - MA Crossover https://www.siam.in/
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Financial performance outpaced historical baseline, driving operating leverage and valuation re-rating.
- •Direct quantitative change registered at 28%
- •Financial performance and operating margins expanded ahead of consensus projections
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.
Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.
At-a-Glance Health & Momentum Check
Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.
Peer & Sector Comparison — Next Research Steps
Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.
Common Questions About DR. LAL PATH LABS (LALPATHLAB)
Key facts on LALPATHLAB share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of DR. LAL PATH LABS (LALPATHLAB)?
As of 16 Oct 2026, the official closing share price of DR. LAL PATH LABS (LALPATHLAB) on NSE/BSE is ₹1,859.90 (-1.34% vs the previous close). Over the past 52 weeks, LALPATHLAB has traded between a low of ₹1,307.60 and a high of ₹2,005.10, with a reported market capitalization of ₹32,331.86 Cr.
What are the historical returns of DR. LAL PATH LABS (LALPATHLAB)?
Based on split-adjusted closing prices through 16 Oct 2026, DR. LAL PATH LABS (LALPATHLAB) recorded the following trailing price returns: 1 Week: -3.81% (from ₹1,933.60 to ₹1,859.90); 15 Days: -7.24% (from ₹2,005.10 to ₹1,859.90); 1 Month: -1.89% (from ₹1,895.70 to ₹1,859.90); 3 Months: +7.34% (from ₹1,732.70 to ₹1,859.90); 6 Months: +31.83% (from ₹1,410.80 to ₹1,859.90); 1 Year: +17.84% (from ₹1,578.35 to ₹1,859.90); 3 Years: +45.63% (from ₹1,277.15 to ₹1,859.90); 5 Years: +3.12% (from ₹1,803.55 to ₹1,859.90). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of DR. LAL PATH LABS (LALPATHLAB)?
DR. LAL PATH LABS (LALPATHLAB) currently trades at a trailing Price-to-Earnings (P/E) ratio of 59.7x, a Price-to-Book (P/B) ratio of 12.9x, and a trailing 12-month dividend yield of 1.03%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).
How much would a past lump-sum or monthly SIP investment in LALPATHLAB have grown?
Based on historical closing prices for DR. LAL PATH LABS (LALPATHLAB): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹1,03,124.39 (+3.1% total return, 0.6% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹6,10,000.00) would be worth ₹8,46,373.20 (+38.8% absolute return). You can test custom amounts and holding periods in the interactive calculator above.
Official Corporate Perspective
Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.